We develop bispecific antibodies that exploit the potential of the natural immune system. Our Amplify•R platform amplifies and redirects endogenous cytokine signaling instead of recombinant cytokines. We avoid issues such as systemic toxicity, immunogenicity and manufacturing concerns.
Company Details
- Employees
- 18
- Founded
- 2023
- Address
- Vancouver, British Columbia, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.reverbtx.com
- Keywords
- Antibody therapeutics, bispecific antibodies, Cytokines, Cytokine signaling, Autoimmune disease, Cancer, drug discovery, drug development, quantitative systems pharmacology, AI aided antibody optimization.
- HQ
- Vancouver, British columbia
Reverb Therapeutics Questions
Reverb Therapeutics's website is http://www.reverbtx.com
Reverb Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/reverbtx
Reverb Therapeutics has
18 employees.
View email and phone details for 18
employees at Reverb Therapeutics.
Reverb Therapeutics's industry is
Biotechnology Research
Reverb Therapeutics's top competitors are
Radiant Biotherapeutics,
Seragene Therapeutics,
Dcx Biotherapeutics Corporation,
Voxcell Bioinnovation,
Amplitude Ventures,
Ability Biotherapeutics,
Admare Bioinnovations,
Kapoose Creek Bio,
Zymeworks Inc.,
Mesentech.
Reverb Therapeutics's categories are Biotechnology Research
Reverb Therapeutics's founding year is 2023
